Skip to main content

Table 2 Univariate analysis of prognostic factors for OS

From: Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer

Variables

 

5-year survival (%)

P value

Age (year)

65

>65

100

88.4

<0.001

Histological type

Ductal

Lobular/Special

94.8

93.8

0.174

Tumor size (cm)

≤2

>2

95.9

91.7

0.005

Lymph node metastasis

Negative

Positive

95.7

90.4

0.001

Estrogen receptor status

Negative

Positive

94.3

94.8

0.827

Progesterone receptor status

Negative

Positive

92.5

95.9

0.619

HER2 status

Negative

Positive

95.3

90.8

0.967

CEA (ng/ml)

<5

≥5

93.7

97.7

0.152

CA15-3 (U/ml)

<23

≥23

94.9

88.9

0.101

PNI

>52.8

52.8

98.3

92.0

0.019

  1. OS overall survival, ER estrogen receptor, PR progesterone receptor, HER-2 human epidermal growth factor receptor 2, CEA carcinoembryonic antigen, CA 15-3 carbohydrate antigen 15-3, PNI prognostic nutritional index